Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 511 AL 525

Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis

Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R.

Brain Behav. 2020 Nov;10(11):e01831. doi: 10.1002/brb3.1831. Epub 2020 Sep 10.

Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease

Zuliani G, Trentini A, Rosta V, Guerrini R, Pacifico S, Bonazzi S, Guiotto A, Passaro A, Seripa D, Valacchi G, Cervellati C.

Sci Rep. 2020 Sep 11;10(1):14980. doi: 10.1038/s41598-020-72168-3.

Effect of statins on amyloidosis in the rodent models of Alzheimer's disease: Evidence from the preclinical meta-analysis

Rahman SO, Hussain S, Alzahrani A, Akhtar M, Najmi AK.

Brain Res. 2020 Dec 15;1749:147115. doi: 10.1016/j.brainres.2020.147115. Epub 2020 Sep 10.

Editorial: Establishing a Trial Ready Cohort to Accelerate Alzheimer's Clinical Trial Enrollment and Treatments

Meyers EA, Carrillo MC.

J Prev Alzheimers Dis. 2020;7(4):202-203. doi: 10.14283/jpad.2020.42.

Editorial: The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) - A Fundamental Ally in AD Prevention Research

Porsteinsson AP, Clark ED.

J Prev Alzheimers Dis. 2020;7(4):206-207. doi: 10.14283/jpad.2020.41.

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview

Aisen PS, Sperling RA, Cummings J, Donohue MC, Langford O, Jimenez-Maggiora GA, Rissman RA, Rafii MS, Walter S, Clanton T, Raman R.

J Prev Alzheimers Dis. 2020;7(4):208-212. doi: 10.14283/jpad.2020.45.

Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease

Bergeron D, Beauregard JM, Soucy JP, Verret L, Poulin S, Matias-Guiu JA, Cabrera-Martín MN, Bouchard RW, Laforce R.

J Alzheimers Dis. 2020;77(4):1569-1577. doi: 10.3233/JAD-200567.

Anticoagulants for Treatment of Alzheimer's Disease

Grossmann K.

J Alzheimers Dis. 2020;77(4):1373-1382. doi: 10.3233/JAD-200610.

Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease

Sharma VK, Singh TG.

Life Sci. 2020 Dec 1;262:118401. doi: 10.1016/j.lfs.2020.118401. Epub 2020 Sep 12.

Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer's disease

Guo M, Yin Z, Chen F, Lei P.

Alzheimers Res Ther. 2020 Sep 14;12(1):109. doi: 10.1186/s13195-020-00670-x.

Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease

Zhang Y, Zhao Y, Zhang J, Yang G.

Neurochem Res. 2020 Nov;45(11):2560-2572. doi: 10.1007/s11064-020-03121-z. Epub 2020 Sep 14.

Alzheimer's disease: natural products as inhibitors of neuroinflammation

Olajide OA, Sarker SD.

Inflammopharmacology. 2020 Dec;28(6):1439-1455. doi: 10.1007/s10787-020-00751-1. Epub 2020 Sep 15.

Deleterious Alteration of Glia in the Brain of Alzheimer's Disease

Kim E, Otgontenger U, Jamsranjav A, Kim SS.

Int J Mol Sci. 2020 Sep 12;21(18):6676. doi: 10.3390/ijms21186676.

Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease

Krishnan S, Shrestha Y, Jayatunga DPW, Rea S, Martins R, Bharadwaj P.

Int J Mol Sci. 2020 Sep 14;21(18):6739. doi: 10.3390/ijms21186739.

Multi-omic comparison of Alzheimer's variants in human ESC-derived microglia reveals convergence at APOE

Liu T, Zhu B, Liu Y, Zhang X, Yin J, Li X, Jiang L, Hodges AP, Rosenthal SB, Zhou L, Yancey J, McQuade A, Blurton-Jones M, Tanzi RE, Huang TY, Xu H.

J Exp Med. 2020 Dec 7;217(12):e20200474. doi: 10.1084/jem.20200474.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias